Prevention of intravascular catheter infections - Insights and prospects for hemodialysis catheters

Nephrologie

Volumn 22, Issue 8, 2001, Pages 449-451

  Mermel, L A ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; CATHETER INFECTION; CONFERENCE PAPER; DISEASE ASSOCIATION; HEMODIALYSIS; HOSPITAL INFECTION; INTRAVASCULAR CATHETER; PATHOGENESIS; PATIENT CARE; SEPSIS;

CATHETERIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SEPSIS;

EID: 0035670281     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Excerpts from the USRDS 1997 Annual Report IV. The USRDS dialysis morbidity and mortality study. Wave 2
2. A meta-analysis of the risk of intravascular device-related bloodstream infection based on 223 published prospective studies
3. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping
4. A prospective study of the mechanisms of infection associated with hemodialysis catheters
5. Catheter-related bacteremia and outcome of attempted salvage in patients undergoing hemodialysis
6. Prevention of intravascular catheter-related infections
7. NKF-DOQI clinical practice guidelines for vascular access. National kidney foundation-dialysis outcomes quality initiative
8. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters
9. Chlorhexidine versus povidone-iodine as cutaneous antisepsis for prevention of vascular-catheter infection
10. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients
11. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection
12. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate
13. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: Effects on rates of blood culture contamination
14. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
15. Infections related to hemodialysis and peritoneal dialysis
16. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine
17. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine
18. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment
19. Unusual complications of a polyurethane PD catheter
20. Spontaneous rupture of polyurethane peritoneal catheter A possible deleterious effect of mupirocin ointment
21. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters
22. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients
23. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients
24. Long-term evaluation of chemoprophylaxis in haemodialysis by nasal mupirocin
25. Infections associated with subclavian dialysis catheters: The key role of nurse training
26. A comparison of two antimicrobial-impregnated central venous catheters
27. Surface treated large bore catheters with silver based coatings versus untreated catheters for extracorporeal detoxification methods
28. Taurolidine activity against vancomycin-intermediate susceptibility Staphylococcus aureus and methicillin-resistant Staphylococcus aureus
29. Taurolidine activity against vancomycin-resistant enterococci
30. Activities of taurolidine in vitro and in experimental enterococcal endocarditis
31. Taurolin for the prevention of parenteral nutrition related infection: Antimicrobial activity and long-term use
32. Two years experience with Dialock™ and CLS™ (a new antimicrobial lock solution)
33. A randomized, double-blind trial comparing minocycline/EDTA vs heparin as a flush solution for hemodialysis catheters